Chemomab Therapeutics Ltd. (CMMB) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $2.33M | -5.6% |
| 2024 | $2.46M | -43.9% |
| 2023 | $4.39M | -14.6% |
| 2022 | $5.14M | +55.3% |
| 2021 | $3.31M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $2.33M | -5.6% |
| 2024 | $2.46M | -43.9% |
| 2023 | $4.39M | -14.6% |
| 2022 | $5.14M | +55.3% |
| 2021 | $3.31M | — |